Skip to main content
Log in

A desirability function-based scoring scheme for selecting fragment-like class A aminergic GPCR ligands

  • Published:
Journal of Computer-Aided Molecular Design Aims and scope Submit manuscript

An Erratum to this article was published on 14 November 2014

Abstract

A physicochemical property-based desirability scoring scheme for fragment-based drug discovery was developed for class A aminergic GPCR targeted fragment libraries. Physicochemical property distributions of known aminergic GPCR-active fragments from the ChEMBL database were examined and used for a desirability function-based score. Property-distributions such as log D (at pH 7.4), PSA, pKa (strongest basic center), number of nitrogen atoms, number of oxygen atoms, and the number of rotatable bonds were combined into a desirability score (FrAGS). The validation of the scoring scheme was carried out using both public and proprietary experimental screening data. The scoring scheme is suitable for the design of aminergic GPCR targeted fragment libraries and might be useful for preprocessing fragments before structure based virtual or wet screening.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

FrAGS:

Fragment Aminergic GPCR Score

GPCR:

G-protein coupled receptor

PSA:

Polar surface area

FBDD:

Fragment-based drug discovery

HTS:

High-throughput screening

FS:

Fragment-screening

7TM:

Seven-transmembrane

SILE:

Size-independent ligand-efficiency

SMILES:

Simplified molecular-input line-entry system

EF:

Enrichment factor

TPR:

True positive rate

TNR:

True negative rate

FPR:

False positive rate

FNR:

False negative rate

ROC:

Receiver operating characteristic

TAAR1 :

Trace-amine receptor subtype 1

5HT1 :

5-Hydroxy-tryptamine receptor subtype 1

References

  1. Fink T, Bruggesser H, Reymond JL (2005) Virtual exploration of the small-molecule chemical universe below 160 daltons. Angew Chem Int Ed 44:1504–1508

    Article  CAS  Google Scholar 

  2. Bohacek RS, McMartin C, Guida WC (1996) The art and practice of structure-based drug design: a molecular modeling perspective. Med Res Rev 16:3–50

    Article  CAS  Google Scholar 

  3. Leeson PD, Springthorpe B (2007) The influence of drug-like concepts on decision-making in medicinal chemistry. Nat Rev Drug Discov 6:881–890

    Article  CAS  Google Scholar 

  4. Hann MM, Keserű GM (2012) Finding the sweet spot: the role of nature and nurture in medicinal chemistry. Nat Rev Drug Discov 11:355–365

    Article  CAS  Google Scholar 

  5. Andrews SP, Brown GA, Christopher JA (2014) Structure-based and fragment-based GPCR drug discovery. ChemMedChem 9:256–275

    Article  CAS  Google Scholar 

  6. ChEMBL GPCR SARfari home page. https://www.ebi.ac.uk/chembl/sarfari/gpcrsarfari

  7. Knime Desktop (Konstanz Information Miner), version 2.9.1 (2014)

  8. Willem J, Nissink M (2009) Simple size-independent measure of ligand efficiency. J Chem Inf Model 49(6):1617–1622

    Article  Google Scholar 

  9. Hann MM, Leach AR, Green DVS, Oprea TI (eds) (2005) Methods and principles in medicinal chemistry, vol 23. Wiley-VCH, Weinheim, pp 43–57

    Google Scholar 

  10. Hopkins AL, Groom CR, Alex A (2004) Ligand efficiency: a useful metric for lead selection. Drug Discov Today 9:430–431

    Article  Google Scholar 

  11. Congreve et al (2003) A ‘rule of three’ for fragment-based lead discovery. Drug Discov Today 8:876–877

    Article  Google Scholar 

  12. GPCRDB information system for G protein-coupled receptors home page. http://www.gpcr.org/7tm/

  13. ChEMBL home page. ftp://ebi.ac.uk/pub/databases/chembl/ChEMBLdb/

  14. RDKit: cheminformatics and machine learning software home page. http://www.rdkit.org/

  15. Balakin KV, Tkachenko SE, Lang SA, Okun I, Ivashchenko AA, Savchuk NP (2002) Property-based design of GPCR-targeted library. J Chem Inf Comput Sci 42:1332–1342

    Article  CAS  Google Scholar 

  16. Marvin, version 5.2, JChem for Excel (2014) Chemaxon, Budapest

  17. Statistica 12, Statsoft home page. http://www.statsoft.com/

  18. Segall MD (2012) Multi-parameter optimization: identifying high quality compounds with a balance of properties. Curr Pharm Des 18:1292–1310

    Article  CAS  Google Scholar 

  19. Harrington EC (1965) The desirability function. Ind Qual Control 21:494–498

    Google Scholar 

  20. Wager TT, Hou X, Verhoest PR, Villalobos A (2010) Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of drug-like properties. ACS Chem Neurosci 1:435–449

    Article  CAS  Google Scholar 

  21. PubChem home page. https://pubchem.ncbi.nlm.nih.gov/

  22. Tanimoto distance as defined in the “Distance Matrix Calculate” node of Knime

Download references

Acknowledgments

We thank for Gedeon Richter Plc for providing GPCR-related fragment-screening and high-throughput screening data for the validation studies and particularly Márton Vass for helpful discussions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to György M. Keserű.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kelemen, Á.A., Ferenczy, G.G. & Keserű, G.M. A desirability function-based scoring scheme for selecting fragment-like class A aminergic GPCR ligands. J Comput Aided Mol Des 29, 59–66 (2015). https://doi.org/10.1007/s10822-014-9804-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10822-014-9804-5

Keywords

Navigation